Bello-Chavolla, Omar Yaxmehen Antonio-Villa, Neftali Eduardo Fermín-Martínez, Carlos A Fernández-Chirino, Luisa Vargas-Vázquez, Arsenio Ramírez-García, Daniel Basile-Alvarez, Martín Roberto Hoyos-Lázaro, Ana Elena Carrillo-Larco, Rodrigo M Wexler, Deborah J
...
Published in
Diabetes care
To estimate diabetes-related mortality in Mexico in 2020 compared with 2017-2019 after the onset of the coronavirus disease 2019 (COVID-19) pandemic. This retrospective, state-level study used national death registries of Mexican adults aged ≥20 years for the 2017-2020 period. Diabetes-related death was defined using ICD-10 codes listing diabetes a...
Aslam, Aisha A. Baksh, R. Asaad Pape, Sarah E. Strydom, Andre Gulliford, Martin C. Chan, Li F. Herault, Yann Strydom, Andre Chan, Li Potier, Marie-Claude
...
Published in
Diabetes Care
OBJECTIVE Down syndrome (DS) is the most common form of chromosomal trisomy. Genetic factors in DS may increase the risk for diabetes. This study aimed to determine whether DS is associated with an increased incidence of diabetes and the relationship with obesity across the life span compared with control patients. RESEARCH DESIGN AND METHODS This ...
Vehik, Kendra Boulware, David Killian, Michael Rewers, Marian McIndoe, Richard Toppari, Jorma Lernmark, Åke Akolkar, Beena Ziegler, Anette-G. Rodriguez, Henry
...
Published in
Diabetes Care
OBJECTIVE Biomarkers predicting risk of type 1 diabetes (stage 3) among children with islet autoantibodies are greatly needed to prevent diabetic ketoacidosis and facilitate prevention therapies. RESEARCH DESIGN AND METHODS Children in the prospective The Environmental Determinants of Diabetes in the Young (TEDDY) study ( n = 707) with confirmed di...
Celli, Alessandra Barnouin, Yoann Jiang, Bryan Blevins, Dean Colleluori, Georgia Mediwala, Sanjay Armamento-Villareal, Reina Qualls, Clifford Villareal, Dennis T
Published in
Diabetes care
Lifestyle intervention is recommended as first-line treatment of diabetes at all ages; however, little is known about the efficacy of lifestyle intervention in older adults with diabetes. We aimed to determine whether lifestyle intervention would improve glycemic control and age-relevant outcomes in older adults with diabetes and comorbidities. A t...
Flood, David Geldsetzer, Pascal Agoudavi, Kokou Aryal, Krishna K Brant, Luisa Campos Caldeira Brian, Garry Dorobantu, Maria Farzadfar, Farshad Gheorghe-Fronea, Oana Gurung, Mongal Singh
...
Published in
Diabetes care
Diabetes prevalence is increasing rapidly in rural areas of low- and middle-income countries (LMICs), but there are limited data on the performance of health systems in delivering equitable and effective care to rural populations. We therefore assessed rural-urban differences in diabetes care and control in LMICs. We pooled individual-level data fr...
Whipple, Mary O Pinto, Ana J Abushamat, Layla A Bergouignan, Audrey Chapman, Kristina Huebschmann, Amy G Masters, Kevin S Nadeau, Kristen J Scalzo, Rebecca L Schauer, Irene E
...
Published in
Diabetes care
Physical activity (PA) is a cornerstone of type 2 diabetes mellitus (T2DM) treatment. Sex differences in PA behavior or barriers/facilitators to PA among individuals with T2DM are unclear. To summarize the evidence related to sex differences in participation in PA and barriers/facilitators to PA among individuals with T2DM across the life span. Sys...
Grams, Morgan E Brunskill, Nigel J Ballew, Shoshana H Sang, Yingying Coresh, Josef Matsushita, Kunihiro Surapaneni, Aditya Bell, Samira Carrero, Juan J Chodick, Gabriel
...
Published in
Diabetes care
To predict adverse kidney outcomes for use in optimizing medical management and clinical trial design. In this meta-analysis of individual participant data, 43 cohorts (N = 1,621,817) from research studies, electronic medical records, and clinical trials with global representation were separated into development and validation cohorts. Models were ...
Kuo, Shihchen Yang, Chun-Ting Herman, William H Lisabeth, Lynda D Ye, Wen
Published in
Diabetes care
To assess the national prevalence of and trends in achieving current guideline-recommended treatment goals and pharmacotherapies for primary and secondary prevention of stroke among U.S. adults with type 2 diabetes (T2D). We performed serial cross-sectional analyses in 4,834 adults aged ≥45 years with T2D who participated in the 2001-2018 National ...
Klein, Klara R Pate, Virginia Assimon, Magdalene M Stürmer, Til Buse, John B Flythe, Jennifer E
Published in
Diabetes care
Fickweiler, Ward Park, Hyunseok Park, Kyoungmin Mitzner, Margalit G Chokshi, Tanvi Boumenna, Tahani Gautier, John Zaitsu, Yumi Wu, I-Hsien Cavallerano, Jerry
...
Published in
Diabetes care
To correlate inflammatory cytokines and vascular endothelial growth factor (VEGF) in vitreous and plasma with vitreous retinol binding protein 3 (RBP3), diabetic retinopathy (DR) severity, and DR worsening in a population with type 1 and type 2 diabetes. RBP3, VEGF, and inflammatory cytokines were measured in plasma and vitreous samples (n = 205) f...
